Clinical trial Recruiting at 1 site Interventional Ages 5 to 18

Using REMS ultrasound to check bone density in children and teens with conditions that lower bone strength

Official title: Observational Study for the Assessment of Bone Mineral Density (BMD) Using REMS Technology

Run by Meyer Children's Hospital IRCCS · NCT07412782 · Data updated 2026-11-12

This project will test whether REMS, a radiation-free ultrasound method, can measure bone mineral density in children and adolescents aged 5–18 who have conditions that weaken their bones.

More Osteoporosis trials

Quick facts

Study typeInterventional
Ages5 Years to 18 Years
SexAll
Enrollment100 (estimated)
SponsorMeyer Children's Hospital IRCCS
Academic / other
Drugs / interventionsradiation
Locations1 site (Florence, Tuscany)
StatusRecruiting
StartedDecember 4, 2025
Main results expectedJune 15, 2026
Study endsDecember 31, 2026
Registry record updatedFebruary 17, 2026
Trial IDNCT07412782 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Children and adolescents aged 5–18 with a documented condition that negatively affects bone health who can provide consent/assent with parental permission are ideal candidates.

Probably not a fit

Children under 5 or over 18, those without bone-impacting conditions, or patients who require DXA-based results for immediate clinical decisions may not receive benefit from this protocol.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Researchers at Meyer Children's Hospital will enroll children and adolescents aged 5–18 with conditions known to impair bone health and perform REMS (Radiofrequency Echographic Multi Spectrometry) scans to obtain bone mineral density measurements. Participants will have clinical history recorded and undergo anthropometric and pubertal assessments, with prior DXA results collected when available. The single-center, non-profit interventional protocol will run about 12 months and uses a non-invasive, radiation-free ultrasound approach. The primary aim is to describe REMS-derived BMD values in pediatric patients with osteoporosis-related conditions and generate preliminary pediatric data.

Why it matters

Potential benefit: If successful, REMS could provide a safe, radiation-free way to monitor bone density in children and reduce dependence on DXA.

How similar studies have gone: REMS has been validated for bone density measurement in adults and early pediatric reports are promising, but standardized pediatric reference values are not yet established.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Written informed consent from adult patients or parents/legal guardians
* Age between 5 and 18 years
* Both sexes and all ethnicities
* Known condition negatively affecting bone health

Exclusion Criteria:

\- Age below 5 years or over 18 years

Where it's running

  • AOU IRCCS Meyer
    Florence, Tuscany, Italy
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.